Effects of peroxisome proliferators on rat liver phospholipids: Sphingomyelin degradation may be involved in hepatotoxic mechanism of perfluorodecanoic acid

Chemical Research in Toxicology

Volumn 11, Issue 5, 1998, Pages 428-440

  Adinehzadeh, Mehdi ^a   Reo, Nicholas V ^a,b,c  

^a WRIGHT STATE UNIVERSITY   (United States)

^b WRIGHT STATE UNIVERSITY   (United States)

^c Department of Emergency Medicine   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

PERFLUORODECANOIC ACID; PHOSPHATIDYLCHOLINE; PHOSPHOLIPID; SPHINGOMYELIN; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL EXPERIMENT; APOPTOSIS; ARTICLE; CARCINOGENICITY; CELL PROLIFERATION; HYDROLYSIS; LIVER TOXICITY; NONHUMAN; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; PEROXISOME; RAT; SIGNAL TRANSDUCTION; TREATMENT PLANNING;

EID: 0031780917     PISSN: 0893228X     EISSN: None     Source Type: Journal    
DOI: 10.1021/tx970155t     Document Type: Article

References (93)

1. Lazarow, P. B., and De Duve, C. (1976) A fatty acyl-CoA oxidizing system in rat liver peroxisomes: enhancement by cloflbrate a hypolipidemic drug. Proc. Natl. Acad. Sci. U.S.A. 73, 2043-2046.
2. Lock, E. A., Mitchell, A. M., and Elcombe, C. R. (1989) Biochemical mechanisms of induction of hepatic peroxisome proliferation Annu. Rev. Pharmacol. Toxicol. 29, 145-163.
3. Reddy, J. K., and Lalwai, N. D. (1983) Carcinogenesis by hepatic peroxisome proliferator: evaluation of the risk of hypolipidemic drugs and industrial plasticizers to humans. Crit. Rev. Toxicol. 12, 1-58 (review).
4. Rao, M., and Reddy, J. (1991) An overview of peroxisome proliferator-induced hepatocarcinogenesis. Environ. Health Perspect. 92, 205-209 (review).
5. Van den Bosch, H., Schutgens, R., Wanders, R., and Tager, J. (1992) Biochemistry of peroxisomes. Annu. Rev. Biochem. 61, 157-97.
6. Intrasuksri, U., and Feller, D. R. (1991) Comparison of the effects of selected monocarboxylic and perfluorinated fatty acids on peroxisome proliferation in primary culture rat hepatocytes. Biochem. Pharmacol. 42, 184-188.
7. Olson, C. T., and Andersen, M. E. (1983) The acute toxicity of perfluorooctanoic and perfluorodecanoic acids in male rats and effects on tissue fatty acids. Toxicol. Appl. Pharmacol. 70, 362- 372.
8. Budroe, J. D., Umemura, T., Angeloff, K., and Williams, G. M. (1992) Dose-response relationships of hepatic acyl-CoA oxidase and catalase activity and liver mitogenesis induced by the peroxisome proliferator ciprofibrate in C57BL/6N and BALB/c mice. Toxicol. Appl. Pharmacol. 113, 192-198.
9. Tanaka, K., Kawamura, S., Matsumoto, H., and Doi, K. (1994) Effects of chronic treatment with clofibric acid on response of rat hepatocytes to mitogenic stimuli. Toxicol. Lett. 74, 141-148.
10. Wada, N., Marsman, D. S., and Popp, J. A. (1992) Dose-related effects of the hepatocarcinogen, Wy-14,643, on peroxisomes and cell replication. Fundam. Appl. Toxicol. 18, 149-154.
11. Abdellatif, A. G., Vamecq, J., Nilsson, R., and Roberfroid, M. (1990) Peroxisome proliferation and modulation of rat liver Carcinogenesis by 2,4-dichlorophenoxyacetic acid, 2,4,5-trichlorophenoxyacetic acid, perfluorooctanoic acid and nafenopin. Carcinogenesis 11, 1899-1902.
12. Abdellatif, A. G., Preat, V., Taper, H. S., and Roberdfroid, M. (1991) The modulation of rat liver Carcinogenesis by perfluorooctanoic acid, a peroxisome proliferator. Toxicol. Appl. Pharmacol. 111, 530-537.
13. Reddy, J. K., and Azarnoff, D. L. (1980) Hypolipidaemic hepatic peroxisome proliferators form a novel class of chemical carcinogens. Nature 283, 397-398.
14. Reddy, J. K., and Rao, M. S. (1986) Viewpoint-Peroxisome proliferators and cancer: mechanisms and implications. Trends Pharmacol. Sci. 7, 438-443.
15. Lake, B. G. (1995) Mechanisms of hepatocarcinogenicity of peroxisome proliferating drugs and chemicals. Annu. Rev. Pharmacol. Toxicol. 35, 483-507.
16. Lemberger, T., Desvergne, B., and Wahli, W. (1996) Peroxisome proliferator-activated receptors: a nuclear receptor signaling pathway in lipid physiology. Annu. Rev. Cell Dev. Biol. 12, 335- 363.
17. Thorne, P. C., Byers, D. M., Palmer, F. B., and Cook, H. W. (1994) Clofibrate and other peroxisomal proliferating agents relatively specifically inhibit synthesis of ethanolamine phosphoglycerides in cultured human fibroblasts. Biochim. Biophys. Acta 1214, 161- 170.
18. Haughon, B., and Spydevold, O. (1992) The mechanism underlying the hypolipidemic effect of perfluorooctanoic acid (PFOA), perfluorooctane sulphonic acid (PFOSA) and clofibric acid. Biochim. Biophys. Acta 1128, 65-72.
19. Parthasarathy, S., Kritchevsky, D., and Baumann, W. J. (1982) Hypolipidemic drugs are inhibitors of phosphatidylcholine snythesis. Proc. Natl. Acad. Sci. U.S.A. 79, 6890-6893.
20. Vazquez, M., Munoz, S., Alegret, M., Adzet, T., Merlos, M., and Laguna, J. C. (1995) Differential effects of fibrates on the acyl compostion of microsomal phospholipids in rats. Er. J. Pharmacol. 116, 2067-2075.
21. Kawashima, Y., Hirose, A., and Kozuka, H. (1984) Selective increase in acylation of 1-acylglycerophosphorylcholine in livers of rats and mice by peroxisome proliferators. Biochim. Biophys. Acta 793, 232-237.
22. Das, A. K., Horie, S., and Hajra, A. K. (1992) Biosynthesis of glycerolipid precursors in rat liver peroxisomes and their transport and conversion to phosphatidate in the endoplasmic reticulum. J. Biol. Chem. 267, 9724-9730.
23. Reo, N. V., Goecke, C. M., Narayanan, L., and Jarnot, B. M. (1994) Effects of perfluoro-n-octanoic acid, perfluoro-n-decanoic acid, and clofibrate on hepatic phosphorus metabolism in rats and guinea pigs in vivo. Toxicol. Appl. Pharmacol. 124, 165-173.
24. Goecke-Flora, C. M., and Reo, N. V. (1996) Effects of carbon chain- length on the hepatotoxicty of perfluorinated fatty acids. A 19F and 31P investigation. Chem. Res. Toxicol. 9, 689-695.
25. Reo, N. V., Narayanan, L., Kling, K. B., and Adinehzadeh, M. (1996) Perfluorodecanoic acid, a peroxisome proliferator, activates phospholipase C, inhibits CTP: phosphocholine cytidylyltransferase, and elevates diacylglycerol in rat liver. Toxicol. Lett. 86, 1-11.
26. Zeisel, S. H. (1993) Choline phospholipids: signal transduction and carcinogenesis. Fed. Am. Soc. Exp. Bio. J. 7, 551-557.
27. Exton, J. H. (1994) Phosphatidylcholine breakdown and signal transduction. Biochim. Biophys. Acta 1212, 26-42.
28. Bielawska, A., Linardic, C. M., and Hannun, Y. A. (1992) Modulation of cell growth and differentiation by ceramide. Fed. Eur. Biochem. Soc. 307, 211-216.
29. Pelech, S. L., and Vance, D. E. (1989) Signal transduction via phosphatidylcholine cycles. Trends Biochem. Sci. 14, 28-30.
30. Hannun, Y. A. (1994) The sphingomyelin cycle and the second messenger function of ceramide. J. Biol. Chem. 269, 3125-3128.
31. Vanden Heuvel, J. P. (1996) Perfluorodecanoic acid as a useful pharmacologic tool for study of peroxisome proliferation. Gen. Pharmacol. 27, 1123-1129.
32. Borges, T., Peterson, R. E., Pitot, H. C., Robertson, L. W., and Glauert, H. P. (1993) Effect of the peroxisome proliferator, Perfluorodecanoic acid, on the promotion of two-state hepatocarcinogenesis in rats. Cancer Lett. 72, 111-120.
33. Lake, B. G. (1995) Peroxisome proliferation: current mechanisms relating to nongenotoxic carcinogenesis. Toxicol. Lett. 82/83, 673- 681.
34. Ruiz-Cabello, J., and Cohen, J. S. (1992) Phospholipid metabolites as indicators of cancer cell function. NMR Biomed. 5, 226-233.
35. Camacho, J., and Rubalcava, B. (1984) Lipid composition of liver plasma membranes from rats intoxicated with carbon tetrachloride. Biochim. Biophys. Acta 776, 97-104.
36. Cullis, P. R., Hope, M. J., de Kruijff, B., Verkleij, A. J., and Tilcock, C. P. S. (1985) Structural properties and functional roles of phospholipids in biological membranes. In Phospholipids and Cellular Regulation (Kuo, J. F., Ed.) pp 1-59, CRC Press, Boca Raton, FL.
37. 31P magnetic resonance phospholipid profiles of neoplastic human breast tissues. Br. J. Cancer 63, 693-698.
38. 31P chemical shifts and absolute quantitation. Q. Magn. Reson. Biol. Med. 3, in press.
39. 31P NMR of extracted phospholipids. J. Lipid Res. 29, 679.
40. Goecke, C. M., Jarnot, B. M., and Reo, N. V. (1992) A comparative toxicological investigation of perfluorocarboxylic acids in rats by fluorine-19 NMR spectroscopy. Chem. Res. Toxicol. 5, 512-519.
41. 13C NMR investigation. Chem. Res. Toxicol. 7, 15-22.
42. Goecke-Flora, C. M., Wyman, J. F., Jarnot, B. M., and Reo, N. V. (1995) Effects of the peroxisome proliferator perfluoro-n-decanoic acid on glucose transport in the isolated perfused rat liver. Chem. Res. Toxicol. 8, 77-81.
43. Milton, M. N., Elcombe, C. R., and Gibson, G. G. (1990) On the (mechanism of induction of microsomal cytochrome P450IVA1 and peroxisome proliferation in rat liver by clofibrate. Biochem. Pharmacol. 40, 2727-2732.
44. Witzmann, F. A., Jarnot, B. M., Parker, D. N., and Clack, J. W. (1994) Modification of hepatic immunoglobulin heavy chain binding protein (BiP/Grp78) following exposure to structurally diverse peroxisome proliferators. Fundam. Appl. Toxicol. 23, 1-8.
45. Bojes, H. K., and Thurman, R. G. (1994) Peroxisome proliferators inhibit acyl CoA synthetase and stimulate protein kinase C in vivo. Toxicol. Appl. Pharmacol. 126, 233-239.
46. Sharma, R., Lake, B. G., and Gibson, G. G. (1988) Co-induction of microsomal cytochrome P-452 and the peroxisomal fatty acid β-oxidation pathway in the rat by clofibrate and di-(2-ethylhexyl)-phthalate. Biochem. Pharmacol. 37, 1203-1206.
47. Okita, J., Castle, P., and Okita, R. (1993) Characterization of cytochromes P450 in the liver of rats treated with di-ethylhexyl phthalate. J. Biochem. Toxicol. 8, 135-144.
48. George, M. E., and Andersen, M. E. (1986) Toxic effects of nonadecafluoro-n-decanoic acid in rats. Toxicol. Appl. Pharmacol. 85, 169-180.
49. Folch, J., Lees, N., and Sloane S. G. H. (1957) A simple method for the isolation and purification of total lipids from animal tissue. J. Biol. Chem. 226, 497-509.
50. Hamilton, S., Hamilton, R. J., and Sewell, P. A. (1992) Extraction of lipids and derivative formation. In Lipid Analysis - A Practical Approach (Hamilton, R. J., and Hamilton, S., Eds.) pp 13-64, IRL Press, New York.
51. 31P NMR at different composition of the solvent system chloroform-methanol- water. Magn. Reson. Med. 26, 46-59.
52. Diagne, A., Fauvel, J., Record, M., Chap, H., and Douste-Blazy, L. (1984) Studies on ether phospholipids. II. Comparative composition of various tissues from human, rat and guinea pig. Biochim. Biophys. Acta 793, 221-231.
53. Van Rafelghem, M. J., Vanden Heuvel, J. P., Menahan, L. A., and Peterson, R. E. (1988) Perfluorodecanoic acid and lipid metabolism in the rat. Lipids 23, 671-678.
54. Kawashima, Y., Mizuguchi, H., Musoh, K., and Kozuka, H. (1994) The mechanism of increased supply of phosphatidylcholine for the proliferation of biological membranes by clofibric acid, a peroxisome proliferator. Biochim. Biophys. Acta 1212, 311-318.
55. Parthasarathy, S., Kritchevsky, D., and Baumann, W. J. (1982) Hypolipidemic drugs are inhibitors of phosphatidylcholine synthesis. Proc. Natl. Acad. Sci. U.S.A. 79, 6890-6893.
56. O, K., and Choy, P. C. (1993) Effects of fasting on phosphatidylcholine biosynthesis in hamster liver: regulation of cholinephosphotransferase activity by endogenous argininosuccinate. Biochem. J. 289, 727-733.
57. Kuksis, A., and Mookerjea, S. (1978) Choline. Natr. Rev. 36, 201- 207.
58. Tijburg, L. B. M., Houweling, M., Geelen, M. J. H., and van Golde, L. M. G. (1988) Effects of dietary conditions on the pool sizes of precursors of phosphatidylcholine and phosphatidylethanolamine synthesis in rat liver. Biochim. Biophys. Acta 959, 1-8.
59. 14C- radiolabeled compounds in vivo. Biochim. Biophys. Acta 1181, 111-121.
60. Lalwani, N., Reddy, K., Qureshi, S. A., and Reddy, J. K. (1981) Development of hepatocellular carcinomas and increased peroxisome fatty acid β-oxidation in rats fed [4-chloro-6-(2,3-xylidino)- 2-pyrimidinylthio]acetic acid (Wy-14,643) in the semipurified diet. Carcinogenesis 2, 645-650.
61. Rao, M., Lawani, N., and Reddy, J. (1984) Sequential histologic study of rat liver during peroxisome proliferator [4-chloro-6-(2,3- xylidino)-2-pyrimidinylthio]acetic acid (Wy-14,643)-induced carcinogenesis. J. Natl. Cancer Inst. 73, 983-990.
62. Sausen, P. J., Lee, D. C., Rose, M. L., and Cattley, R. C. (1995) Elevated 8-hydroxydeoxyguanosine in hepatic DNA of rats following exposure to peroxisome proliferators: relationship to mitochondrial alterations. Carcinogenesis 16, 1795-1801.
63. Reddy, J. K., Rao, M. S., Azarnoff, D. L., and Sell, S. (1979) Mitogenic and carcinogenic effects of a hypolipidemic peroxisome proliferator, [4-chloro-6-(2,3-xylidino)-2-pyrimidinylthio]acetic acid (Wy-14,643) in rat and mouse liver. Cancer Res. 39, 152-161.
64. Marsman, D. S., and Popp, J. A. (1989) Importance of basophilic hepatocellular foci in the development of hepatic tumors induced by the peroxisome proliferator, Wy-14,643. Proc. Am. Assoc. Cancer Res. 30, 193.
65. Reddy, J. K., and Qureshi, S. A. (1979) Tumorigenicity of the hypolipidemic peroxisome proliferator ethyl-α-p-chlorophenoxy- isobutyrate (clofibrate) in rats. Br. J. Cancer 40, 476-482.
66. Svoboda, D. J., and Azarnoff, D. L. (1979) Tumors in male rats fed ethyl chlorophenoxyisobutyrate, a hypolipidemic drug. Cancer Res. 39, 3419-3428.
67. National Toxicology Program. (1983) Carcinogenesis bioassay of di(2-ethylhexyl)phthalate (CAS No. 117-81-7) in F344 rats and B6C3F1 mice. NTP Technical Report Series No. 217, NIH, Bethesda, MD.
68. 1 mice. J. Toxicol. Environ. Health 10, 797-815.
69. Obeid, L. M., and Hannun, Y. A. (1995) Ceramide: a stress signal and mediator of growth suppression and apoptosis. J. Cell. Biochem. 58, 191-198.
70. Hannun, Y. A., and Obeid, L. M. (1995) Ceramide: an intracellular signal for apoptosis. Trends Biochem. Sci. 20, 73-77.
71. Hannun, Y. A. (1996) Functions of ceramide in coordinating cellular responses to stress. Science 274, 1855-1859.
72. Kim, M., Linardic, C., Obeid, L., and Hannun, Y. (1991) Identification of sphingomeylin turnover as an effector mechanism for the action of tumor necrosis factor alpha and gamma-interferon. Specific role in cell differentiation. J. Biol. Chem. 266, 484-489.
73. Dressler, K. A., Mathis, S., and Kolensnic, R. M. (1992) Tumor necrosis factor-α activates the sphingomyelin signal transduction pathway in a cell-free system. Science 259, 1769-1771.
74. 3-induced HL-60 cell differentiation. J. Biol. Chem. 265, 15823- 15831.
75. Mellman, I., Fuchs, R., and Helenius, A. (1986) Acidification of the endocytic and exocytic pathways. Annu. Rev. Biochem. 55, 663-700.
76. Kronke, M., Schutze, S., Wiegmann, K., and Machleidt, T. (1996) Sphingomyelinases and TNF-induced apoptosis. Cell. Physiol. Biochem. 6, 337-344.
77. Schutze, S., Potthoff, K., Machleidt, T., Berkovic, D., Wiegmann, K., and Kronke, M. (1992) TNF activates NF-κB by phosphatidylcholine-specific phospholipase C-induced "acidic" sphingomyelin breakdown. Cell 71, 765-776.
78. 3 pituitary cells. J. Biol. Chem. 263, 6534-6537.
79. Merrill, A. H. (1989) Modulation of protein kinase C and diverse cell functions by sphingosine - a pharmacologically interesting compound linking sphingolipids and signal transduction. Biochim. Biophys. Acta 1010, 131-139.
80. Nakamura, S.-i., and Nishizuka, Y. (1994) Lipid mediators and protein kinase C activation for the intracellular signaling network. J. Biochem. 115, 1029-1034.
81. Sohal, P. S., and Cornell, R. B. (1990) Sphingosine inhibits the activity of rat liver CTP: phosphocholine cytidylyltransferase. J. Biol. Chem. 265, 11746-11750.
82. Long, S. D., and Pekala, P. H. (1996) Lipid mediators of insulin resistance: ceramide signaling down-regulates GLUT4 gene transcription in 3T3-L1 adipocytes. Biochem. J. 319, 179-184.
83. Bojes, H. K., and Thurman, R. G. (1996) Peroxisome proliferators activate Kupffer cells in vivo. Cancer Res. 56, 1-4.
84. Bojes, H. K., Germolec, D. R., Simeonova, P., Bruccolei, A., Schoonhoven, R., Luster, M. I., and Thurman, R. G. (1997) Antibodies to tumor necrosis factor a prevent increase in cell replication due to the potent peroxisome proliferator; Wy-14,643. Carcinogenesis 18, 669-674.
85. Bojes, H. K., Rose, M. L., Keller, B. J., Germolec, D. R., Simeonova P., Luster, M. I., and Thurman, R. G. (1997) Mitogenic actions of peroxisome proliferators: involvement of protein kinase C and tumor necrosis factor α. Drug Metab. Rev. 29, 235-260.
86. Beyer, H. S., and Theologides, A. (1993) Tumor necrosis factor-α is a direct hepatocyte mitogen in the rat. Biochem. Mol. Biol. Int. 29, 1-4.
87. Heller, R. A., and Kronke, M. (1994) Tumor necrosis factor receptor-mediated signaling pathways. J. Cell Biol. 126, 5-9.
88. Rolfe, M., James, N. H., and Roberts, R. A. (1997) Tumour necrosis factor α (TNFα) suppresses apoptosis and induces DNA synthesis in rodent hepatocytes: a mediator of the hepatocarcinogenesis of peroxisome proliferators? Carcinogenesis 18, 2277-2280.
89. Zhang, B., Berger, J., Hu, E., Szalkowski, D., White-Carrington, S., Spiegelman, B., and Moller, D. (1996) Negative Regulation of Peroxisome Proliferator-Activated Receptor-γ Gene Expression Contributes to the Antiadipogenic Effects of Tumor Necrosis Factor-α. Mol. Endocrinol. 10, 1457-1466.
90. Beier, K., Volkl, A., and Fahimi, H. D. (1997) TNF-α downregulates the peroxisome proliferator activated receptor-α and the mRNAs encoding peroxisomal proteins in rat liver. Fed. Eur. Biochem. Soc. 412, 385-387.
91. Decker, K. (1990) Biologically active products of stimulated liver macrophages (Kupffer cells). Eur. J. Biochem. 192, 245-261.
92. Wilson, M. W., Lay, T. L., Chow, C. K., Tai, H.-H., Robertson, L. W., and Glauert, H. P. (1995) Altered hepatic eicosanoid concentration in rats treated with the peroxisome proliferators ciprofibrate and perfluorodecaonic acid. Arch. Toxicol. 69, 491-497.
93. Kawashima, Y., Kobayashi, H., and Kozuka, H. (1995) Characterization of hepatic responses of rat to administration of perfluorooctanoic and perfluorodecanoic acids at low levels. Toxicology 99, 169-178.